Primary fatty amides are potential plasma biomarkers for AD
(2019) In Nature Reviews Neurology- Abstract
A new study has found that levels of primary fatty amides in plasma correlate with amyloid-β pathology and other Alzheimer disease (AD)-related phenomena. In addition to identifying potential plasma biomarkers for AD, the findings suggest new avenues for investigation into the early stages of AD.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/683971b0-80b4-4021-ab9d-95cc30df807b
- author
- Mattsson, Niklas LU and Hansson, Oskar LU
- organization
- publishing date
- 2019-06-28
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nature Reviews Neurology
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:85068325644
- pmid:31253949
- ISSN
- 1759-4758
- DOI
- 10.1038/s41582-019-0229-6
- language
- English
- LU publication?
- yes
- id
- 683971b0-80b4-4021-ab9d-95cc30df807b
- date added to LUP
- 2019-07-12 09:39:06
- date last changed
- 2024-03-19 17:45:47
@misc{683971b0-80b4-4021-ab9d-95cc30df807b, abstract = {{<p>A new study has found that levels of primary fatty amides in plasma correlate with amyloid-β pathology and other Alzheimer disease (AD)-related phenomena. In addition to identifying potential plasma biomarkers for AD, the findings suggest new avenues for investigation into the early stages of AD.</p>}}, author = {{Mattsson, Niklas and Hansson, Oskar}}, issn = {{1759-4758}}, language = {{eng}}, month = {{06}}, publisher = {{Nature Publishing Group}}, series = {{Nature Reviews Neurology}}, title = {{Primary fatty amides are potential plasma biomarkers for AD}}, url = {{http://dx.doi.org/10.1038/s41582-019-0229-6}}, doi = {{10.1038/s41582-019-0229-6}}, year = {{2019}}, }